Lipid profile after switching from a TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV (M. Łomiak, Z. Gajek, J. Stępnicki, A. Lembas, T. Mikuła, & A. Wiercińska-Drapało , Trans.). (2023). Journal of Medical Science, 92(4), e808. https://doi.org/10.20883/medical.e808